These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38910270)

  • 1. Open Innovation or Traditional Patenting Strategies to Efficiently Address Health Emergencies? How Patent Information Was Used Towards Effective Treatments for COVID-19.
    de Almeida TDME; Cordeiro DS
    Recent Pat Biotechnol; 2024 Jun; ():. PubMed ID: 38910270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Information Disclosed in Patent Documents being the Source to Address Emergencies: A Strategy to Achieve Technological Developments Addressing COVID-19.
    Martins TD; Cordeiro DS
    Recent Pat Biotechnol; 2021 Oct; 15(2):148-163. PubMed ID: 33797389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When speed matters: a discussion on the benefits of a grace period in patent law to accelerate pharmaceutical innovation in times of pandemic.
    Ozyhar T; Barnabei L; Myrick D
    J Law Biosci; 2022; 9(1):lsac004. PubMed ID: 35233290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of network positions in scientific collaboration on pharmaceutical firms' technological innovation performance: Moderating roles of scientific collaboration strength and patent stock.
    Wang XX; Jiao HY
    Front Public Health; 2022; 10():980845. PubMed ID: 36033805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic.
    Bacigalupo ML; Pignataro MF; Scopel CT; Kondratyuk S; Mellouk O; Chaves GC
    Front Med (Lausanne); 2023; 10():1287542. PubMed ID: 38126073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.
    Martinez-Grau MA; Alvim-Gaston M
    Pharmaceut Med; 2019 Jun; 33(3):193-198. PubMed ID: 31933287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technological Innovations in Disease Management: Text Mining US Patent Data From 1995 to 2017.
    Huang M; Zolnoori M; Balls-Berry JE; Brockman TA; Patten CA; Yao L
    J Med Internet Res; 2019 Apr; 21(4):e13316. PubMed ID: 31038462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incremental innovation in healthcare in Spain during the COVID-19 pandemic].
    Argüello A; Oruezabal RI; Reyes M; Álvarez P
    Rev Esp Salud Publica; 2023 Mar; 97():. PubMed ID: 36883658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Patent Landscape and Innovation of Hydrogel-based Bioinks Used for 3D Bioprinting.
    Fatimi A
    Recent Adv Drug Deliv Formul; 2022; 16(2):145-163. PubMed ID: 35507801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Innovation Trends for Plant-Based Vaccines Production: A Patent Analysis.
    Frisio DG; Ventura V
    Plants (Basel); 2021 Nov; 10(12):. PubMed ID: 34961028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategic Patenting by Pharmaceutical Companies - Should Competition Law Intervene?
    Gurgula O
    IIC Int Rev Ind Prop Copyr Law; 2020; 51(9):1062-1085. PubMed ID: 33132411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enabling policy planning and innovation management through patent information and co-authorship network analyses: a study of tuberculosis in Brazil.
    Vasconcellos AG; Morel CM
    PLoS One; 2012; 7(10):e45569. PubMed ID: 23056208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovation strategies used by companies in Poland during the pandemic.
    Kozioł-Nadolna K
    Procedia Comput Sci; 2022; 207():3198-3207. PubMed ID: 36275375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct from the COVID-19 crisis: research and innovation sparks in Brazil.
    Rosa MFF; da Silva EN; Pacheco C; Diógenes MVP; Millett C; Gadelha CAG; Santos LMP
    Health Res Policy Syst; 2021 Jan; 19(1):10. PubMed ID: 33478499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.